Surgery Partners Inc
$ 15.90
-0.62%
16 Jan - close price
- Market Cap 2,056,534,000 USD
- Current Price $ 15.90
- High / Low $ 16.44 / 15.84
- Stock P/E N/A
- Book Value 13.50
- EPS -1.36
- Next Earning Report 2026-03-02
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.01 %
- 52 Week High 26.16
- 52 Week Low 14.94
About
Surgery Partners, Inc. (SGRY) is a leading operator of surgical facilities and ancillary services in the United States, headquartered in Brentwood, Tennessee. The company is dedicated to providing high-quality, cost-effective outpatient surgical care through its extensive network of ambulatory surgery centers and related offerings. By prioritizing patient outcomes and enhancing surgical workflows, Surgery Partners is well-positioned to leverage the growing demand for outpatient procedures, aligning with the industry’s shift toward value-based care and improved healthcare delivery. With its strategic focus and operational expertise, the company is set to capture significant market opportunities in the evolving healthcare landscape.
Analyst Target Price
$25.45
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-10 | 2025-08-05 | 2025-05-05 | 2025-02-24 | 2024-11-12 | 2024-08-06 | 2024-05-07 | 2024-02-26 | 2023-11-07 | 2023-08-01 | 2023-05-01 | 2023-03-01 |
| Reported EPS | 0.13 | -0.02 | 0.04 | 0.44 | -0.2512 | 0.21 | 0.1 | 0.44 | 0.19 | 0.28 | 0.08 | 0.27 |
| Estimated EPS | 0.2129 | 0.16 | 0.07 | 0.3769 | 0.25 | 0.2 | 0.07 | 0.38 | 0.16 | 0.08 | 0.01 | 0.19 |
| Surprise | -0.0829 | -0.18 | -0.03 | 0.0631 | -0.5012 | 0.01 | 0.03 | 0.06 | 0.03 | 0.2 | 0.07 | 0.08 |
| Surprise Percentage | -38.9385% | -112.5% | -42.8571% | 16.7418% | -200.48% | 5% | 42.8571% | 15.7895% | 18.75% | 250% | 700% | 42.1053% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-02 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.27 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SGRY
2026-01-18 17:58:13
The article explores Surgery Partners Inc (SGRY) as a potentially undervalued investment opportunity in the healthcare sector, focusing on its strategy of shifting medical procedures from traditional hospitals to more cost-effective outpatient surgery centers. It discusses the company's business model, growth potential through scaling and partnerships, and risk factors like debt and regulatory changes. The author concludes that SGRY could be a "conditional cop" for investors comfortable with volatility and healthcare-specific risks, but not for those seeking a low-drama investment.
2026-01-11 12:58:43
Surgery Partners announced the pricing of its offering of $425 million in 7.750% senior notes due 2030 at par. The offering is expected to close on January 19, 2026, subject to customary closing conditions. The company plans to use the net proceeds, along with cash on hand, to redeem all of its outstanding 10.000% senior notes due 2027.
2026-01-09 12:58:43
Sivik Global Healthcare LLC significantly increased its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 76%, acquiring an additional 95,000 shares to bring its total holding to 220,000 shares, now valued at approximately $4.76 million. Despite this increased institutional interest, Surgery Partners recently missed its quarterly EPS estimates, reporting $0.13 against an anticipated $0.19, and analysts have adjusted price targets downwards while maintaining a "Moderate Buy" rating with an average target of $27.11. The company's stock currently trades around $15.60, with a market capitalization of $2.02 billion.
2026-01-09 03:16:00
RBC Capital and Mizuho Securities have maintained a bullish outlook on Surgery Partners (SGRY). RBC Capital reiterated its Buy rating with a $31 price target, citing strong long-term growth prospects, while Mizuho Securities, despite lowering its price target to $19, kept an Outperform rating, expecting 2026 to be a "pivotal year" for the healthcare sector with improved margins. Surgery Partners operates a network of over 200 healthcare facilities across 30 states.
2026-01-08 23:30:41
Voya Investment Management LLC significantly reduced its stake in Surgery Partners, Inc. (SGRY) by 86.5% during the third quarter, selling 88,405 shares and retaining 13,842 shares valued at $300,000. Despite this, other institutions exhibited mixed activity, with some materially increasing or initiating positions. Surgery Partners missed Q3 earnings estimates, reporting $0.13 EPS against an anticipated $0.19, leading analysts to trim price targets while maintaining a "Moderate Buy" consensus.
2026-01-06 11:13:00
Surgery Partners, Inc. (SGRY) is analyzed as an attractive investment in the healthcare sector, with a current trading price of $15.34 and an average analyst target price of $25.45, indicating a 65.94% upside potential. Despite current negative EPS due to reinvestment, the company shows solid revenue growth and strong free cash flow, supported by bullish analyst sentiment. Its focus on ambulatory surgical centers positions it well for future growth in the evolving healthcare landscape.
